259 GENES FOUND

? »

« prev | Page of 6 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HBA2Hemoglobin, alpha 2Disease related genes
FDA approved drug targets
Plasma proteins
Tissue enriched
HBBHemoglobin, betaDisease related genes
FDA approved drug targets
Plasma proteins
Tissue enriched
HDAC1Histone deacetylase 1Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HDAC2Histone deacetylase 2Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HDAC3Histone deacetylase 3Enzymes
FDA approved drug targets
Expressed in all
HDAC6Histone deacetylase 6Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Expressed in all
HDAC9Histone deacetylase 9Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HMGCR3-hydroxy-3-methylglutaryl-CoA reductaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
HMMRHyaluronan-mediated motility receptor (RHAMM)CD markers
FDA approved drug targets
Mixed
HPD4-hydroxyphenylpyruvate dioxygenaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Group enriched
HPRT1Hypoxanthine phosphoribosyltransferase 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HRH1Histamine receptor H1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
HSD3B1Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Tissue enriched
HSD3B2Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Tissue enriched
HTR2A5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR2B5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
HTR75-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
RAS pathway related proteins
Tissue enhanced
ICAM1Intercellular adhesion molecule 1Cancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IDEInsulin-degrading enzymeEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
IKBKBInhibitor of kappa light polypeptide gene enhancer in B-cells, kinase betaDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
RAS pathway related proteins
Expressed in all
IMPDH1IMP (inosine 5'-monophosphate) dehydrogenase 1Disease related genes
Enzymes
FDA approved drug targets
Expressed in all
IMPDH2IMP (inosine 5'-monophosphate) dehydrogenase 2Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
ITGA2BIntegrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)Cancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
JUNJun proto-oncogeneCancer-related genes
FDA approved drug targets
Transcription factors
Expressed in all
KCNA10Potassium voltage-gated channel, shaker-related subfamily, member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNA5Potassium voltage-gated channel, shaker-related subfamily, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNB1Potassium voltage-gated channel, Shab-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC1Potassium voltage-gated channel, Shaw-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNC2Potassium voltage-gated channel, Shaw-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNQ1Potassium voltage-gated channel, KQT-like subfamily, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel, KQT-like subfamily, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KDRKinase insert domain receptor (a type III receptor tyrosine kinase)Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
KEAP1Kelch-like ECH-associated protein 1Cancer-related genes
FDA approved drug targets
Expressed in all
KITV-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homologCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
LCKLymphocyte-specific protein tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Tissue enhanced
LHCGRLuteinizing hormone/choriogonadotropin receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
LIPFLipase, gastricEnzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MAOAMonoamine oxidase ADisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Mixed
MAOBMonoamine oxidase BEnzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Mixed
MAP1AMicrotubule-associated protein 1AFDA approved drug targets
Plasma proteins
Tissue enriched
MAP2Microtubule-associated protein 2FDA approved drug targets
Plasma proteins
Tissue enriched
MAP2K1Mitogen-activated protein kinase kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
MAP2K2Mitogen-activated protein kinase kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
MAP4Microtubule-associated protein 4FDA approved drug targets
Plasma proteins
Expressed in all
MAPK1Mitogen-activated protein kinase 1Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Plasma proteins
RAS pathway related proteins
Expressed in all
MAPK3Mitogen-activated protein kinase 3Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
MAPTMicrotubule-associated protein tauCandidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Tissue enhanced
METMet proto-oncogeneCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
METAP2Methionyl aminopeptidase 2Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
MGAMMaltase-glucoamylase (alpha-glucosidase)Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Group enriched

« prev | Page of 6 | next »